Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Chemicals | 80.9 | 67.5 | 79.2 | 104.8 | 117.1 | 105.4 | | 125.8 |
Biofuels | 315.1 | 253.8 | 125.3 | 100.4 | 173.9 | 169.6 | | 173.8 |
Non-US | 1.3 | 1.2 | 1.1 | 1.8 | 2.0 | 3.4 | | |
Total revenues | 396.0 | 321.4 | 204.5 | 205.2 | 291.0 | 275.0 | 57.2 | 299.6 |
Revenue growth [+] | 23.2% | 57.2% | -0.4% | -29.5% | 5.8% | 380.9% | -80.9% | -12.4% |
Chemicals | 19.8% | -14.7% | -24.5% | -10.5% | 11.1% | | | -13.9% |
Biofuels | 24.1% | 102.5% | 24.8% | -42.3% | 2.5% | | | -11.2% |
Non-US | 8.5% | 8.6% | -35.1% | -12.2% | -41.0% | | | |
Cost of goods sold [+] | 367.0 | 297.8 | 173.2 | 131.1 | 217.6 | 254.8 | 10.3 | 242.2 |
Cost of product sales | | | | | | | | 233.1 |
Transportation costs | | | | | | | | 2.4 |
Related party costs | | | | | | | | 6.7 |
Gross profit | 29.0 | 23.5 | 31.3 | 74.1 | 73.4 | 20.3 | 46.9 | 57.5 |
Gross margin | 7.3% | 7.3% | 15.3% | 36.1% | 25.2% | 7.4% | 81.9% | 19.2% |
Selling, general and administrative [+] | 7.4 | 6.5 | 5.4 | 4.9 | 5.7 | 6.1 | 7.1 | 7.1 |
Sales and marketing | | | | | | | | 5.0 |
General and administrative | 7.4 | 6.5 | 5.4 | 4.9 | 5.7 | 6.1 | 7.1 | 2.2 |
Other selling, general and administrative | | | | | | | | 5.0 |
Research and development | 3.4 | 3.5 | 3.0 | 3.2 | 3.5 | 3.7 | 2.7 | 2.7 |
Other operating expenses | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.5 | 0.6 |
EBITDA [+] | 28.0 | 23.4 | 33.5 | 77.4 | 74.7 | 21.5 | 47.3 | 57.2 |
EBITDA growth | 19.9% | -30.3% | -56.7% | 3.7% | 246.8% | -54.5% | -17.2% | -12.2% |
EBITDA margin | 7.1% | 7.3% | 16.4% | 37.7% | 25.7% | 7.8% | 82.8% | 19.1% |
Depreciation and amortization | 10.5 | 10.5 | 11.2 | 12.1 | 11.2 | 11.6 | 10.8 | 10.2 |
EBIT [+] | 17.5 | 12.9 | 22.3 | 65.3 | 63.4 | 9.9 | 36.5 | 47.0 |
EBIT growth | 36.0% | -42.3% | -65.8% | 2.9% | 541.6% | -72.9% | -22.2% | -16.3% |
EBIT margin | 4.4% | 4.0% | 10.9% | 31.8% | 21.8% | 3.6% | 63.9% | 15.7% |
Interest income, net [+] | -0.1 | -0.1 | -0.2 | -0.2 | -0.2 | -0.2 | 6.0 | 5.1 |
Interest expense | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
Interest income | | | | | | | 6.2 | 5.2 |
Other income (expense), net [+] | -3.7 | 3.2 | 9.6 | 14.7 | -3.1 | 6.9 | -1.7 | -0.2 |
Unrealized gain (loss) on marketable securities | -8.5 | -0.1 | -4.4 | 4.6 | -12.0 | -0.7 | -1.3 | 0.1 |
Other | 0.0 | 0.1 | 8.3 | 0.0 | -0.3 | -0.2 | -0.4 | -0.2 |
Pre-tax income | 13.7 | 15.9 | 31.8 | 79.8 | 60.2 | 16.6 | 40.8 | 51.9 |
Income taxes | -1.5 | -10.3 | -14.8 | -8.4 | 7.0 | -6.9 | -15.5 | 5.4 |
Tax rate | | | | | 11.7% | | | 10.5% |
Net income | 15.2 | 26.3 | 46.6 | 88.2 | 53.2 | 23.5 | 56.3 | 46.4 |
Net margin | 3.8% | 8.2% | 22.8% | 43.0% | 18.3% | 8.5% | 98.5% | 15.5% |
|
Basic EPS [+] | $0.35 | $0.60 | $1.06 | $2.02 | $1.22 | $0.54 | $1.29 | $1.07 |
Growth | -42.1% | -43.6% | -47.2% | 65.8% | 125.8% | -58.4% | 21.1% | -12.9% |
Diluted EPS [+] | $0.35 | $0.60 | $1.06 | $2.02 | $1.22 | $0.54 | $1.29 | $1.07 |
Growth | -42.1% | -43.6% | -47.2% | 65.8% | 125.9% | -58.4% | 21.1% | -12.9% |
|
Dividends per share [+] | $0.24 | $2.74 | $3.24 | $0.24 | $0.24 | $2.53 | $0.24 | $0.24 |
Growth | -91.2% | -15.4% | 1250.0% | 0.0% | -90.5% | 951.7% | -0.3% | -49.9% |
|
Shares outstanding (basic) [+] | 43.8 | 43.8 | 43.7 | 43.7 | 43.7 | 43.7 | 43.5 | 43.4 |
Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.3% | 0.3% | 0.2% |
Shares outstanding (diluted) [+] | 43.8 | 43.8 | 43.7 | 43.7 | 43.7 | 43.7 | 43.5 | 43.4 |
Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.3% | 0.2% | 0.1% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|